Midlothian, Virginia (VA) Medicines-Patent and Proprietary Companies

Featured companies
Cvs/Pharmacy
13180 Midlothian Turnpike
Midlothian VA 23113
(804) 379-9060

Cvs/Pharmacy is a privately held company in Midlothian, VA .
Cvs/Pharmacy
151 Pike View Drive
Midlothian VA 23113
(804) 594-0185
Cvs/Pharmacy
13800 Hull Street Road
Midlothian VA 23112
(804) 739-2198
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Cvs Pharmacy Inc
11114 Hull Street Road
Midlothian VA 23112
(804) 744-4442
Cvs Pharmacy Inc
13620 Genito Road
Midlothian VA 23112
(804) 744-6930
Everet Darbey
13502 Midlothian Turnpike
Midlothian VA 23113
(804) 379-9943

Everet Darbey is a privately held company in Midlothian, VA and is a Unknown business.
Pharmacy Consultation Services Crxs LLC
13613 Winning Colors Lane
Midlothian VA 23112
(804) 739-2617
Rite Aid
6921 Lake Harbour Drive
Midlothian VA 23112
(804) 639-6580
Ss Kresge Co
11003 Hull Street Road
Midlothian VA 23112
(804) 674-5291
Walgreens
11119 Hull Street Road
Midlothian VA 23112
(804) 744-5986
Whereorg has 10 results under Medicines-Patent and Proprietary Companies in Midlothian, VA.

Other categories for location Chesterfield, Virginia

Other locations for category Medicines-Patent and Proprietary


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020